✦ LIBER ✦

The recombinant kringle domain of urokinase plasminogen activator inhibits in vivo malignant glioma growth

✍ Scribed by Chung Kwon Kim; Sung Hee Hong; Young Ae Joe; Byoung-Shik Shim; Suk-Keun Lee; Yong-Kil Hong

Book ID: 108583800
Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 329 KB
Volume: 98
Category: Article
ISSN: 1347-9032
DOI: 10.1111/j.1349-7006.2006.00378.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Inhibition of human malignant glioma gro

Inhibition of human malignant glioma growth In vivo by human recombinant plasminogen kringles 1–3

✍ Young-Ae Joe; Yong-Kil Hong; Dong-Sup Chung; Youn-Joo Yang; Joon-Ki Kang; Youn-S 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 321 KB 👁 1 views

Human malignant gliomas are highly vascularized and aggressive tumors. Angiogenesis inhibitors have been shown to induce regression of a variety of primary and metastatic tumors in vivo. However, their usefulness in treating brain tumors is not well understood. Angiostatin, a multiple kringle (1-4 o

The kringle domain of tissue-type plasmi

The kringle domain of tissue-type plasminogen activator inhibits in vivo tumor growth

✍ Byoung-Shik Shim; Byoung-Hak Kang; Yong-Kil Hong; Hyun-Kyung Kim; Il-Ha Lee; Soo 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 847 KB

Inhibition of endothelial cell prolifera

Inhibition of endothelial cell proliferation by the recombinant kringle domain of tissue-type plasminogen activator

✍ Hyun-Kyung Kim; Soo Young Lee; Ho-Kyun Oh; Byoung-Hak Kang; Hyeun-Ju Ku; Yoon Le 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 270 KB

A hybrid protein of urokinase growth-fac

A hybrid protein of urokinase growth-factor domain and plasminogen-activator inhibitor type 2 inhibits urokinase activity and binds to the urokinase receptor

✍ D. James BALLANCE; Julian M. MARSHALL; Ian R. COTTINGHAM; John STEVEN; Sarah J. 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 697 KB

Enhancement of anti-tumor activity by lo

Enhancement of anti-tumor activity by low-dose combination of the recombinant urokinase kringle domain and celecoxib in a glioma model

✍ Chung Kwon Kim; Young Ae Joe; Suk-Keun Lee; Eun-Kyoung Kim; Eunju O; Hyun-Kyung 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 869 KB

RNA interference targeting urokinase-typ

RNA interference targeting urokinase-type plasminogen activator receptor inhibits tumour growth of oral squamous cell carcinoma in vivo

✍ X. Liang; H. Zhou; Y. Tang; X. Yang; J. Yang; G. Zhu; M. Zheng; C. Zhang 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 90 KB